An Alternate‐Day Corticosteroid Regimen in Maintenance Therapy of Giant Cell Arteritis
- 12 January 1981
- journal article
- research article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 209 (1-6) , 347-350
- https://doi.org/10.1111/j.0954-6820.1981.tb11605.x
Abstract
It is well established that the side-effects of corticosteroid treatment can be reduced by administering the steroid on alternate days. Twenty-seven patients with giant cell arteritis were given daily treatment initially, followed by a gradual transition to alternate-day treatment. It was possible to maintain 18 (67 %) of 27 patients on this regimen. In 9 (33%) the regimen was abandoned because of clinical symptoms on the “day off”. These patients, however, could be maintained with a single morning dose of the corticosteroid. Morning plasma Cortisol levels on the treatment day were normal in all patients treated with 20 mg prednisolone or less every other day.Keywords
This publication has 16 references indexed in Scilit:
- Prognosis of Giant Cell Arteritis Including Temporal Arteritis and Polymyalgia RheumaticaActa Medica Scandinavica, 1981
- Treatment and Prognosis in Polymyalgia Rheumatica and Temporal ArteritisActa Medica Scandinavica, 1979
- Giant Cell Arteritis: Clinical Features and Involvement of Different OrgansScandinavian Journal of Rheumatology, 1978
- Giant‐cell Arteritis, Temporal Arteritis and Polymyalgia RheumaticaActa Medica Scandinavica, 1977
- GLUCOCORTICOID THERAPYMedicine, 1976
- Studies on an Intermittent Corticosteroid Dosage RegimenNew England Journal of Medicine, 1963
- Neurologic aspects of temporal arteritisNeurology, 1960
- THE OCULAR CRISIS OF THE TEMPORAL ARTERITIS SYNDROME (HORTON)*)Acta Ophthalmologica, 1958
- TEMPORAL ARTERITIS AND ITS TREATMENT WITH CORTISONE AND A.C.T.H.The Lancet, 1953